Gastric cancer cells inhibit natural killer cell proliferation and induce apoptosis via prostaglandin E2

OncoImmunology

Volumn 5, Issue 2, 2016, Pages

  Li, Tuanjie ^a   Zhang, Qi ^b,c   Jiang, Yuming ^a   Yu, Jiang ^a   Hu, Yanfeng ^a   Mou, Tingyu ^a   Chen, Guihua ^b,c   Li, Guoxin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Guangdong Provincial Key Laboratory of Liver Disease Research   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cyclooxygenase 2; gastric cancer; natural killer cell; prostaglandin E2

Indexed keywords

EID: 84959432985     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1069936     Document Type: Article

References (34)

1. M.D.Vesely, M.H.Kershaw, R.D.Schreiber, M.J.Smyth. Natural innate and adaptive immunity to cancer. Ann Rev Immunol 2011; 29:235-71; PMID:21219185; http://dx.doi.org/10.1146/annurev-immunol-031210-101324
2. S.I.Grivennikov, F.R.Greten, M.Karin. Immunity, inflammation, and cancer. Cell 2010; 140:883-99; PMID:20303878; http://dx.doi.org/10.1016/j.cell.2010.01.025
3. P.Parham. Immunology. NK cells lose their inhibition. Science 2004; 305:786-7; PMID:15297654; http://dx.doi.org/10.1126/science.1102025
4. E.Vivier, D.H.Raulet, A.Moretta, M.A.Caligiuri, L.Zitvogel, L.L.Lanier, W.M.Yokoyama, S.Ugolini. Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331:44-9; PMID:21212348; http://dx.doi.org/10.1126/science.1198687
5. E.Narni-Mancinelli, B.N.Jaeger, C.Bernat, A.Fenis, S.Kung, A.De Gassart, S.Mahmood, M.Gut, S.C.Heath, J.Estellé et al. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science 2012; 335:344-8; PMID:22267813; http://dx.doi.org/10.1126/science.1215621
6. Y.Wu, D.M.Kuang, W.D.Pan, Y.L.Wan, X.M.Lao, D.Wang, X.F.Li, L.Zheng. Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions. Hepatology 2013; 57:1107-16; PMID:23225218; http://dx.doi.org/10.1002/hep.26192
7. E.Vivier, S.Ugolini, D.Blaise, C.Chabannon, L.Brossay. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 2012; 12:239-52; PMID:22437937; http://dx.doi.org/10.1038/nri3174
8. A.B.Keener. Natural killers: Cataloging immune cells for immunotherapy. Nat Med 2015; 21:207-8; PMID:25742450; http://dx.doi.org/10.1038/nm0315-207
9. M.R.Parkhurst, J.P.Riley, M.E.Dudley, S.A.Rosenberg. Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression. Clin Cancer Res 2011; 17:6287-97; PMID:21844012; http://dx.doi.org/10.1158/1078-0432.CCR-11-1347
10. A.Mantovani, P.Romero, A.K.Palucka, F.M.Marincola. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet 2008; 371:771-83; PMID:18275997; http://dx.doi.org/10.1016/S0140-6736(08)60241-X
11. S.Grosch, T.J.Maier, S.Schiffmann, G.Geisslinger. Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 2006; 98:736-47; PMID:16757698; http://dx.doi.org/10.1093/jnci/djj206
12. J.H.Chen, C.J.Perry, Y.C.Tsui, M.M.Staron, I.A.Parish, C.X.Dominguez, D.W.Rosenberg, S.M.Kaech. Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection. Nat Med 2015; 21:327-34; PMID:25799228; http://dx.doi.org/10.1038/nm.3831
13. K.Ng, J.A.Meyerhardt, A.T.Chan, K.Sato, J.A.Chan, D.Niedzwiecki, L.B.Saltz, R.J.Mayer, A.B.Benson3rd, P.L.Schaefer, et al. Aspirin and COX-2 inhibitor use in patients with stage III colon cancer. J Natl Cancer Inst 2015; 107:345; PMID:25432409; http://dx.doi.org/10.1093/jnci/dju345
14. M.H.McLean, E.M.El-Omar. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol 2014; 11:664-74; PMID:25134511; http://dx.doi.org/10.1038/nrgastro.2014.143
15. M.Sahin, E.Sahin, S.Gumuslu. Cyclooxygenase-2 in cancer and angiogenesis. Angiology 2009; 60:242-53; PMID:18505747; http://dx.doi.org/10.1177/0003319708318378
16. L.Martinet, M.J.Smyth. Balancing natural killer cell activation through paired receptors. Nat Rev Immunol 2015;15:243-54; PMID:25743219; http://dx.doi.org/10.1038/nri3799
17. L.Xu, J.Stevens, M.B.Hilton, S.Seaman, T.P.Conrads, T.D.Veenstra, D.Logsdon, H.Morris, D.A.Swing, N.L.Patel et al. COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. Sci Translat Med 2014; 6:242ra84; http://dx.doi.org/10.1126/scitranslmed.3008455
18. P.Kalinski. Regulation of immune responses by prostaglandin E2. J Immunol 2012; 188:21-8; PMID:22187483; http://dx.doi.org/10.4049/jimmunol.1101029
19. J.Reader, D.Holt, A.Fulton. Prostaglandin E2 EP receptors as therapeutic targets in breast cancer. Cancer Metastasis Rev 2011; 30:449-63; PMID:22002714; http://dx.doi.org/10.1007/s10555-011-9303-2
20. N.Kundu, X.Ma, D.Holt, O.Goloubeva, S.Ostrand-Rosenberg, A.M.Fulton. Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function. Breast Cancer Res Treat 2009; 117:235-42; PMID:18792778; http://dx.doi.org/10.1007/s10549-008-0180-5
21. M.J.Smyth, Y.Hayakawa, K.Takeda, H.Yagita. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2002; 2:850-61; PMID:12415255; http://dx.doi.org/10.1038/nrc928
22. T.Li, Y.Yang, X.Hua, G.Wang, W.Liu, C.Jia, Y.Tai, Q.Zhang, G.Chen. Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO. Cancer Lett 2012; 318:154-61; PMID:22182446; http://dx.doi.org/10.1016/j.canlet.2011.12.020
23. R.Salgado, C.Denkert, S.Demaria, N.Sirtaine, F.Klauschen, G.Pruneri, S.Wienert, G.Van den Eynden, F.L.Baehner, F.Penault-Llorca et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol 2015; 26:259-71; PMID:25214542; http://dx.doi.org/10.1093/annonc/mdu450
24. C.I.Diakos, K.A.Charles, D.C.McMillan, S.J.Clarke. Cancer-related inflammation and treatment effectiveness. Lancet Oncol 2014; 15:e493-e503; PMID:25281468; http://dx.doi.org/10.1016/S1470-2045(14)70263-3
25. F.R.Villegas, S.Coca, V.G.Villarrubia, R.Jimenez, M.J.Chillon, J.Jareno, M.Zuil, L.Callol. Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung cancer 2002; 35:23-8; PMID:11750709; http://dx.doi.org/10.1016/S0169-5002(01)00292-6
26. L.Senovilla, E.Vacchelli, J.Galon, S.Adjemian, A.Eggermont, W.H.Fridman, C.Sautès-Fridman, Y.Ma, E.Tartour, L.Zitvogel et al. Trial watch: Prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology 2012; 1:1323-43; PMID:23243596; http://dx.doi.org/10.4161/onci.22009
27. G.Pietra, C.Manzini, S.Rivara, M.Vitale, C.Cantoni, A.Petretto, M.Balsamo, R.Conte, R.Benelli, S.Minghelli et al. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res 2012; 72:1407-15; PMID:22258454; http://dx.doi.org/10.1158/0008-5472.CAN-11-2544
28. Y.Mao, D.Sarhan, A.Steven, B.Seliger, R.Kiessling, A.Lundqvist. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity. Clin Cancer Res 2014; 20:4096-106; PMID:24907113; http://dx.doi.org/10.1158/1078-0432.CCR-14-0635
29. P.Serafini. Editorial: PGE2-producing MDSC: a role in tumor progression? J leukoc Biol 2010; 88:827-9; PMID:21041513; http://dx.doi.org/10.1189/jlb.0510303
30. E.Eruslanov, I.Daurkin, J.Ortiz, J.Vieweg, S.Kusmartsev. Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE(2) catabolism in myeloid cells. J leukoc Biol 2010; 88:839-48; PMID:20587738; http://dx.doi.org/10.1189/jlb.1209821
31. C.C.Uphoff, H.G.Drexler. Detection of mycoplasma in leukemia-lymphoma cell lines using polymerase chain reaction. Leukemia 2002; 16:289-93; PMID:11840297; http://dx.doi.org/10.1038/sj.leu.2402365
32. Y.Zhuang, L.S.Peng, Y.L.Zhao, Y.Shi, X.H.Mao, W.Chen, K.C.Pang, X.F.Liu, T.Liu, J.Y.Zhang et al. CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology 2012; 143:951–62.e8; PMID:22710190; http://dx.doi.org/10.1053/j.gastro.2012.06.010
33. T.Glatzer, M.Killig, J.Meisig, I.Ommert, M.Luetke-Eversloh, M.Babic, D.Paclik, N.Blüthgen, R.Seidl, C.Seifarth et al. RORgammat(+) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 2013; 38:1223-35; PMID:23791642; http://dx.doi.org/10.1016/j.immuni.2013.05.013
34. Y.Wu, Q.Zhao, C.Peng, L.Sun, X.F.Li, D.M.Kuang. Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. J Pathol 2011; 225:438-47; PMID:21826665; http://dx.doi.org/10.1002/path.2947